Adverse Reactions/Side Effects The following important adverse reactions are described below and elsewhere in the labeling: Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis [see Warnings and Precautions (5.1)] Volume Depletion [see Warnings and Precautions (5.2)] Genitourinary Infections, including Urosepsis, Pyelonephritis, Necrotizing Fasciitis of the Perineum (Fourniers Gangrene), and Genital Mycotic Infections [see Warnings and Precautions (5.3)] Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues [see Warnings and Precautions (5.4)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice
Tirzepatide is an FDA-approved medication that offers a novel approach to weight management by leveraging dual hormone pathways to reduce appetite and improve metabolic health
Dose escalation, timing relative to large meals, existing reflux disease, and vagal or diabetic neuropathy each affect the strength with which gut signals reach the brainstem
GoodRx, a platform for medication savings, shares what you should know about oral semaglutide (Wegovy) for weight loss how it works, how to take it, and more.Key takeaways: Wegovy (semaglutide) was initially available as a weekly injection
A 2021 medical study stated medication-induced gastroparesis is reversible and discontinuing is generally curative, with repeat studies showing improvement and resolution
